February 11, 2016 — Royal Philips announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Expression MR400, a new technology that monitors patients undergoing magnetic resonance imaging (MRI). The MR400 provides intensive care unit (ICU)-comparable, bedside-quality monitoring in the MR suite for all patients, including those with serious medical conditions or who require anesthesia.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now